Chemotherapy of metastatic colon cancer
- Authors: Fedyanin M.Y.1, Tryakin A.А.1, Tjulandin S.A.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: Vol 1, No 2 (2012)
- Pages: 26-34
- Section: REVIEW
- Published: 25.02.2015
- URL: https://onco-surgery.info/jour/article/view/17
- DOI: https://doi.org/10.17650/2220-3478-2012-0-2-26-34
- ID: 17
Cite item
Full Text
Abstract
Colorectal cancer is one of the leading causes of cancer incidence and mortality. In 2008 inRussian Federation55 719 new cases of colorectal cancer were diagnosed and 37 911 patients died of this disease. A significant progress was achieved in metastatic colorectal cancer treatment during the last decades. A lot of treatment options became available: from 5-fluoruracil monotherapy to combined treatment treatment schemes including surgery. A group of patients with isolated liver metastases was distinguished, who can achieve 5-year survival rate of 40 % after systemic treatment and surgery. Today, based on clinical data and molecular analysis, we come close to individualized treatment of this patient group. In this literature review results of metastatic colorectal cancer chemotherapy are being analyzed and rational treatment tactic is proposed based on therapy goals.
Keywords
About the authors
M. Yu. Fedyanin
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: fedianinmu@mail.ru
Russian Federation
A. А. Tryakin
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: fake@neicon.ru
Russian Federation
S. A. Tjulandin
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: fake@neicon.ru
Russian Federation
References
Supplementary files


